NEW YORK (GenomeWeb) – The TranSmart Foundation and the Informatics for Integrating Biology and the Bedside (i2b2) Foundation announced yesterday that they have agreed to merge into a single foundation focused on providing open-source biomedical software and databases for precision medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.